Research report on current and evolving technologies in drug delivery

The drug delivery market is a rapidly evolving force in the pharmaceutical industry. Within this segment injectables have a significant role to play at present with the increasing use of proteins and peptides. Although a relatively underdeveloped market at present the injectable drug delivery has a substantial pipeline, and with significant strides in development of nanotechnology and DNA drug delivery over the past 5 years, injectable drug delivery is set to be an important component of the future pharmaceuitical landscape.

This report evaluates the current and evolving technologies used for injectable drug delivery, the key therapuetic areas, the barriers and driving forces for this market, the competitive landscape is analysed according the technology type, and key pipeline companies and products are examined. Leading companies in the injectable drug delivery market are also profiled.

Key Features of this report

• Overview of injectable drug delivery technologies and their mechanisms.

• Profile of key therapeutic areas for injectable drug delivery including, acromegaly, diabetes, hepatitis C, HIV, oncology, pain, schizophrenia and substance abuse.

• Analysis of key therapeutic areas will include incidence rates, current injectable treatments and future directions for injectable drug delivery in this area.

• Market drivers for injectable drug delivery will be examined including patient adherence and the reduction of toxicity, as well as how advances in nanotechnology and genomics are driving the market.

• The threat from alternative delivery methods will also be examined as well as current regulatory issues.

Scope of this report

• Understand current market dynamics and drivers for injectable drug delivery.

• Understand the injectable drug delivery market in terms of segment sizes as well as market shares.

• Understand the key technologies used for injectable drug delivery and their mechanisms.

• Evaluate major market participants, their technologies, pipeline and weaknesses and strengths.

• Develop an understand of the developmental pipeline for injectable drug delivery and key innovations driving the future direction of the market.

Key Market Issues

• Injectable drug delivery has a significant potential to drive the future market, however, at present only a few key products have enjoyed significant market success.

• Nanotechnology and DNA drug delivery are set to shape future markets significantly, both have a very strong pipeline, but DNA delivery has yet to have any proven market success.

• Therapy areas where adherence is a significant problem area present a major area of opportunity for injectable delivery. Current key market successes such as Risperdal Consta demonstrate the role that injectable delivery has to play in overcoming adherence problems, and future potential in areas such as mental health, diabetes and HIV are set to ensure the continued success of injectable delivery.

Key findings from this report

• The injectable drug delivery market holds great potential but is still in its infancy. Successes so far are dominated by just a few products.

• The injectable delivery pipeline is very strong and disproportionate at present to the current market, suggesting it may have a much more significant influence on the future market with the increased use of proteins and peptides.

• DNA technology is yet to prove successful, despite significant investment and research there has been only 1 successful marketed product, which has not achieved great market success.

• Nanotechnology holds the greatest potential for success in the near future. Current products enjoy some increasing success and there is a strong pipeline with products in high revenue therapy areas.

• Although sustained release products will continue to be used, there is little development in this field with a greater move towards nanotechnology and DNA drug delivery.

Key questions answered

• What are the key technologies used to enable drug delivery using injections?

• What are the mechanisms of key technologies?

• What are the key therapy areas for injectable drug delivery? What is their incidence?

• What products are used at present for key therapy areas and how will injectable delivery shape the future treatment of these therapy areas?

• What is the size of the current injectable delivery market and what is the share of the key products and market participants?

Source: Reportlinker